Adrián Llerena-Ruiz
AuthID: R-000-HSC
11
TITLE: CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits
AUTHORS: Pedro Dorado; Eva M Penas LLedo; Adrian LLerena;
PUBLISHED: 2007, SOURCE: PHARMACOGENOMICS, VOLUME: 8, ISSUE: 11
AUTHORS: Pedro Dorado; Eva M Penas LLedo; Adrian LLerena;
PUBLISHED: 2007, SOURCE: PHARMACOGENOMICS, VOLUME: 8, ISSUE: 11
12
TITLE: No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients Full Text
AUTHORS: Pedro Dorado; Roland Berecz; Eva M Penas Lledo; Alfredo de la Rubia; Adrian LLerena;
PUBLISHED: 2007, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 63, ISSUE: 5
AUTHORS: Pedro Dorado; Roland Berecz; Eva M Penas Lledo; Alfredo de la Rubia; Adrian LLerena;
PUBLISHED: 2007, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 63, ISSUE: 5
13
TITLE: Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs
AUTHORS: Dorado, P; Berecz, R; Penas Lledo, EM; Caceres, MC; LLerena, A;
PUBLISHED: 2006, SOURCE: CURRENT DRUG TARGETS, VOLUME: 7, ISSUE: 12
AUTHORS: Dorado, P; Berecz, R; Penas Lledo, EM; Caceres, MC; LLerena, A;
PUBLISHED: 2006, SOURCE: CURRENT DRUG TARGETS, VOLUME: 7, ISSUE: 12
14
TITLE: Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use
AUTHORS: Dorado, P; Caceres, MC; Pozo Guisado, E; Wong, ML; Licinio, J; Llerena, A;
PUBLISHED: 2005, SOURCE: BIOTECHNIQUES, VOLUME: 39, ISSUE: 4
AUTHORS: Dorado, P; Caceres, MC; Pozo Guisado, E; Wong, ML; Licinio, J; Llerena, A;
PUBLISHED: 2005, SOURCE: BIOTECHNIQUES, VOLUME: 39, ISSUE: 4
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef15
TITLE: Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship Full Text
AUTHORS: Dorado, P; Berecz, R; Caceres, MC; Gonzalez, I; Cobaleda, J; Llerena, A;
PUBLISHED: 2005, SOURCE: CLINICAL CHEMISTRY AND LABORATORY MEDICINE, VOLUME: 43, ISSUE: 3
AUTHORS: Dorado, P; Berecz, R; Caceres, MC; Gonzalez, I; Cobaleda, J; Llerena, A;
PUBLISHED: 2005, SOURCE: CLINICAL CHEMISTRY AND LABORATORY MEDICINE, VOLUME: 43, ISSUE: 3
16
TITLE: The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions
AUTHORS: Berecz, R; Dorado, P; De La Rubia, A; Caceres, MC; Degrell, I; LLerena, A;
PUBLISHED: 2004, SOURCE: CURRENT DRUG TARGETS, VOLUME: 5, ISSUE: 6
AUTHORS: Berecz, R; Dorado, P; De La Rubia, A; Caceres, MC; Degrell, I; LLerena, A;
PUBLISHED: 2004, SOURCE: CURRENT DRUG TARGETS, VOLUME: 5, ISSUE: 6
17
TITLE: QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
AUTHORS: Llerena, A; Berecz, R; Dorado, P; de la Rubia, A;
PUBLISHED: 2004, SOURCE: JOURNAL OF PSYCHOPHARMACOLOGY, VOLUME: 18, ISSUE: 2
AUTHORS: Llerena, A; Berecz, R; Dorado, P; de la Rubia, A;
PUBLISHED: 2004, SOURCE: JOURNAL OF PSYCHOPHARMACOLOGY, VOLUME: 18, ISSUE: 2
18
TITLE: Relationship between haloperidol plasma concentration, Debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients
AUTHORS: Llerena, A; de la Rubia, AC; Berecz, R; Dorado, P;
PUBLISHED: 2004, SOURCE: PHARMACOPSYCHIATRY, VOLUME: 37, ISSUE: 2
AUTHORS: Llerena, A; de la Rubia, AC; Berecz, R; Dorado, P;
PUBLISHED: 2004, SOURCE: PHARMACOPSYCHIATRY, VOLUME: 37, ISSUE: 2
19
TITLE: Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions Full Text
AUTHORS: LLerena, A; Dorado, P; Berecz, R; Gonzalez, AP; Penas LLedo, EM;
PUBLISHED: 2004, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 59, ISSUE: 12
AUTHORS: LLerena, A; Dorado, P; Berecz, R; Gonzalez, AP; Penas LLedo, EM;
PUBLISHED: 2004, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 59, ISSUE: 12
INDEXED IN: 
Scopus WOS
Scopus WOS20
TITLE: Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios Full Text
AUTHORS: Dorado, P; Berecz, R; Caceres, MC; Llerena, A;
PUBLISHED: 2003, SOURCE: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, VOLUME: 789, ISSUE: 2
AUTHORS: Dorado, P; Berecz, R; Caceres, MC; Llerena, A;
PUBLISHED: 2003, SOURCE: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, VOLUME: 789, ISSUE: 2
